Literature DB >> 520309

Sequestration and turnover of guinea-pig milk proteins and chicken ovalbumin in Xenopus oocytes.

C Lane, S Shannon, R Craig.   

Abstract

The stability and distribution of proteins within the living cell can be studied using Xenopus laevis oocytes. Microinjection of messenger RNAs and secretory proteins, followed by cell fractionation, shows that transfer of ovalbumin and milk proteins across intracellular membranes of the oocyte only occurs during their synthesis. Thus milk protein primary translation products, made in the wheat germ cell-free system, when injected into oocytes remain in the cytosol and are not recovered within membrane vesicles. Such miscompartmentalized primary milk proteins are rapidly degraded (t 1/2 0.6 +/- 0.1 h). In contrast, processed milk proteins, extracted from oocytes injected with mammary gland RNA, are relatively stable when introduced into the cytosolic compartment (t 1/2 alpha-lactalbumin 20 +/- 8 h, casein A 6 h, casein B 4 h, casein C 8.3 h). The primary ovalbumin product is also stable (t 1/2 22 +/- 9 h). Indirect evidence that rapid degradation of miscompartmentalized milk protein primary translation products may occur in vivo was obtained by the injection of massive amounts of ovalbumin and milk protein mRNA. Under these conditions there is no accumulation of primary milk protein translation products, but a polypeptide resembling the unglycosylated ovalbium wheat germ primary product can be detected in the cytosol. Only the glyclosylated forms of ovalbumin are found in the oocyte membrane vesicle fraction. We discuss the roles played by the presence of detachable signal sequences and the absence of secondary modifications in determining the rate of degradation of primary translation products within the cytosol.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 520309     DOI: 10.1111/j.1432-1033.1979.tb19743.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

1.  Identification and subsequent phosphorylation of sequestered partially processed caseins in the lactating guinea-pig mammary gland.

Authors:  A P Boulton; J C Pascall; R K Craig
Journal:  Biochem J       Date:  1984-09-01       Impact factor: 3.857

2.  Synthetic leader peptide modulates secretion of proteins from microinjected Xenopus oocytes.

Authors:  R Koren; Y Burstein; H Soreq
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

3.  Stimulation of Xenopus oocyte protein synthesis by microinjected adenovirus RNA.

Authors:  J D Richter; N C Jones; L D Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

4.  Heterogeneity of guinea-pig caseins synthesized and sequestered by cell-free protein-synthesizing systems.

Authors:  J C Pascall; A P Boulton; D Parker; L Hall; R K Craig
Journal:  Biochem J       Date:  1981-05-15       Impact factor: 3.857

5.  Envelope proteins of Semliki Forest virus synthesized in Xenopus oocytes are transported to the cell surface.

Authors:  A Huth; T A Rapoport; L Kääriäinen
Journal:  EMBO J       Date:  1984-04       Impact factor: 11.598

6.  Accumulation of the isolated carboxy-terminal domain of histone H1 in the Xenopus oocyte nucleus.

Authors:  C Dingwall; J Allan
Journal:  EMBO J       Date:  1984-09       Impact factor: 11.598

7.  Cell surface expression of murine, rat, and human Fc receptors by Xenopus oocytes.

Authors:  E Pure; A D Luster; J C Unkeless
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

8.  Subcellular compartmentalization of maize storage proteins in Xenopus oocytes injected with zein messenger RNAs.

Authors:  W J Hurkman; L D Smith; J Richter; B A Larkins
Journal:  J Cell Biol       Date:  1981-05       Impact factor: 10.539

9.  Fate of secretory proteins trapped in oocytes of Xenopus laevis by disruption of the cytoskeleton or by imbalanced subunit synthesis.

Authors:  A Colman; J Morser; C Lane; J Besley; C Wylie; G Valle
Journal:  J Cell Biol       Date:  1981-12       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.